NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
28/04/2021
Voltar para busca
Dado oficial do USPTO
FAPON
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
28/04/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10
Data de depósito
28/07/2009
Data de registro
08/03/2011
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/04/2021
Última transação
28/04/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
SHENZHEN, CN
Examinador
LAM, HAI-LY
Unidade examinadora
M30
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
FAPON BIOTECH INC.
Shenzhen Feipeng Kechuang partnership (L.P.)
FAPON BIOTECH INC.
FAPON BIOTECH INC.
Representantes
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparationsother than for medical or veterinary purposes; biological preparationsother than for medical or veterinary purposesantibodiesantigenspeptidesenzymeslysatesvectorslipidsstem cellscell strainsstrainstags and markerstag and marker antibodiesantigens and proteinsall for research purposes; cultures of microorganisms other than for medical and veterinary use; biochemical catalysts; chemical reagents for non-medical purposes
Classe 5
Vaccines; biological preparations for medical purposes; diagnostic preparations for medical purposes; bacterial and bacteriological preparations for medical or veterinary purposes; blood derivativeshematology calibrators and controlsblood plasmablood substitutes for human or veterinary usecoagulation factorimmunoglobulintissue type plasminogen activatorC-reactive proteinhuman antithrombin; veterinary preparations for treatment of intestinal bacteria; anti-infective products for veterinary use; pharmaceutical preparations for the treatment of addiction in the fields of smoking or drugs; pharmaceutical preparations for the treatment of urinary incontinence; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of cerebrovascular diseases and disorders; pharmaceutical preparations for the treatment of anxietydepressioninsomniacognitive disorders and diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of menopausal symptoms and disorders; pharmaceutical preparationsanti-infective preparations; pharmaceutical preparationsanti-viral preparations; pharmaceutical preparationsimmunological preparations; pharmaceutical preparationsanalgesic preparations; pharmaceutical preparationsantiemetic preparations; pharmaceutical preparationsvaccine preparations; biochemical preparations for medical or veterinary purposes; bacterial preparations for medical and veterinary use; none of the foregoing being ophthalmic preparations or otorhinolaryngological preparations
Classe 10
Testing apparatus for medical purposesskin allergy testing apparatus; testing apparatus for medical purposesblood glucose testing apparatus in the nature of blood glucose meter and blood drawing apparatus; apparatus and instruments for medical and veterinary diagnosisequipments and devices in the nature of immuno analysersnucleid acid analysers; bacteriologic analysersmicrobiologic analysers used for testing or for manual or for automated testing in medical and clinical applications; medical diagnostic apparatus for medical purposesultrasonic and magnetic resonance imaging diagnostic apparatusX-ray computer tomography scannerscomputed tomography (CT) apparatusdiagnostic X-ray apparatus; blood testing apparatus
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
71AG
REGISTERED-SEC.71 ACCEPTED
28/04/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/04/2021
ES71
TEAS SECTION 71 RECEIVED
05/03/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
31/10/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
18/06/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
19/05/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/03/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
20/03/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/03/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/03/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/03/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/03/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
15/08/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/03/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/03/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/08/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
17/08/2017
71AG
REGISTERED-SEC.71 ACCEPTED
17/08/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/08/2017
ES71
TEAS SECTION 71 RECEIVED
28/07/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/02/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/06/2011
FIMP
FINAL DISPOSITION PROCESSED
15/06/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/06/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
08/03/2011
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/01/2011
CHPB
POST PUBLICATION AMENDMENT - ENTERED
02/12/2010
APET
ASSIGNED TO PETITION STAFF
10/11/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/11/2010
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/11/2010
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
16/09/2010
PUBO
PUBLISHED FOR OPPOSITION
24/08/2010
NPUB
NOTICE OF PUBLICATION
04/08/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
22/07/2010
ALIE
ASSIGNED TO LIE
22/07/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2010
RFNP
REFUSAL PROCESSED BY IB
01/01/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/12/2009
RFRR
REFUSAL PROCESSED BY MPU
09/12/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/12/2009
CNRT
NON-FINAL ACTION WRITTEN
06/12/2009
MAFR
APPLICATION FILING RECEIPT MAILED
05/12/2009
DOCK
ASSIGNED TO EXAMINER
01/12/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2009
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
30/11/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/11/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FAPON ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.